Yasunobu Takatama

Yasu Takatama practices primarily in the area of mergers and acquisitions, general corporate, and related commercial matters in the health care industry.

Prior to earning his Japanese law degree, Yasu worked in the clinical development and regulatory departments of a Japanese publicly listed pharmaceutical company for nine years, and he has extensive industry experience in the interpretation and implementation of Japanese laws as they relate to clinical trials and pharmaceutical affairs, particularly with transactions that require approvals from the Ministry of Health, Labour and Welfare on pharmaceutical compounds and products and related marketing licenses. [1]